Alzamend Neuro Inc (ALZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 04-2021 | 03-2021 | 01-2021 | 10-2020 | 09-2020 | |
| Operating Expenses | 1,221 | 0 | 1,116 | 1,298 | 1,009 |
| Operating Income | -1,221 | N/A | -1,116 | -1,298 | -1,009 |
| Interest Expense | 42 | 0 | 66 | 51 | 0 |
| Other Income | 6 | 0 | 62 | -6 | 2 |
| Pre-tax Income | -1,257 | 0 | -1,119 | -1,354 | -1,007 |
| Net Income Continuous | -1,257 | 0 | -1,119 | -1,354 | -1,317 |
| Net Income | $-1,257 | $0 | $-1,119 | $-1,354 | $-1,317 |
| EPS Basic Total Ops | -13.49 | N/A | -26.99 | -26.99 | N/A |
| EPS Basic Continuous Ops | -22.97 | N/A | -20.89 | -25.29 | N/A |
| EPS Diluted Total Ops | -13.49 | N/A | -26.99 | -26.99 | N/A |
| EPS Diluted Continuous Ops | -22.97 | N/A | -20.89 | -25.29 | N/A |
| EBITDA(a) | $-1,221 | $N/A | $-1,116 | $-1,298 | $-1,009 |